Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The Сompany's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging.

Type
Public
HQ
Waltham, US
Founded
2003
Size (employees)
229 (est)
Radius Health was founded in 2003 and is headquartered in Waltham, US
Report incorrect company information

Key People/Management at Radius Health

Michael Wyzga

Michael Wyzga

President & CEO
Gary Hattersley

Gary Hattersley

Senior Vice President, Preclinical Development
Michael Franken

Michael Franken

Senior Vice President, Chief Business Officer

Radius Health Office Locations

Radius Health has an office in Waltham
Waltham, US (HQ)
950 Winter St
Show all (1)
Report incorrect company information

Radius Health Financials and Metrics

Radius Health Financials

USD

Net income (FY, 2017)

(254.2 m)

EBIT (FY, 2017)

(249 m)

Market capitalization (20-Apr-2018)

1.5 b

Cash (31-Dec-2017)

118.6 m

EV

1.7 b
Radius Health's current market capitalization is $1.5 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

General and administrative expense

77.5 m186.7 m

R&D expense

107.4 m83.1 m

Operating expense total

184.9 m269.8 m

EBIT

(67.4 m)(59.4 m)(99.1 m)(184.9 m)(249 m)
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cost of goods sold

105 k

General and administrative expense

6 m8.5 m13.6 m17.2 m19.2 m38.1 m50.1 m47.7 m

R&D expense

16.3 m18.2 m27.5 m26.9 m27.5 m19.5 m19.7 m21 m

Operating expense total

22.3 m26.7 m41.1 m44.1 m46.7 m57.6 m69.8 m68.7 m
Annual
USDFY, 2013FY, 2016FY, 2017

Cash

12.3 m258.6 m118.6 m

Accounts Receivable

28.3 m4.4 m

Inventories

334 k2.3 m4.4 m

Current Assets

12.6 m334.8 m269.5 m
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

104.4 m120.6 m198.6 m174.6 m135.1 m446.9 m

Accounts Receivable

1.2 m11.7 m

Inventories

1.6 m3.1 m

Current Assets

440.1 m406.1 m373.5 m288.7 m223.6 m490.7 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(60.7 m)(101.5 m)(182.8 m)(254.2 m)

Depreciation and Amortization

27 k586 k2 m

Inventories

1.7 m2.1 m7 m4.6 m(4.4 m)

Accounts Payable

(250 k)2.3 m6.2 m(100 k)(2.2 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(23 m)(28.3 m)(40.5 m)(43.4 m)(46.2 m)(56.9 m)

Accounts Payable

2.7 m279 k1.2 m1.3 m3.2 m3.3 m4.5 m3.8 m3 m2.7 m6.7 m
USDY, 2017

EV/EBIT

-6.7 x

EV/CFO

-8.1 x

Financial Leverage

1.9 x
Show all financial metrics
Report incorrect company information

Radius Health News and Updates

Report incorrect company information